Sutro Biopharma Inc.
STRO | NASDAQ
$16.35
$0 (0.00%)
Sep 22, 2026, 11:50 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 102.48M | 62.04M | 153.73M | 67.77M | 61.88M | 42.72M |
Cost of Revenue | 7.32M | 7.22M | 6.82M | 8.29M | 9.77M | 76.96M |
Gross Profit | 95.16M | 54.83M | 146.92M | 59.48M | 52.11M | -34.24M |
Operating Income | -104.95M | -238.45M | -89.28M | -128.94M | -98.52M | -71.06M |
Interest Income | 9.25M | 44.43M | 14.51M | 3.46M | 577K | 1.51M |
Pretax Income | -191.18M | -225.1M | -88.6M | -116.7M | -105.54M | -32.13M |
Net Income | -191.09M | -227.46M | -106.79M | -119.2M | -105.54M | -32.13M |
Selling & General & Admin | 41.02M | 48.45M | 62.58M | 59.54M | 56M | 36.82M |
Research & Development | 166.42M | 252.04M | 180.43M | 137.17M | 104.4M | 76.96M |
Other Expenses | -7.32M | -7.22M | -6.82M | -8.29M | -9.77M | -76.96M |
Operating Expenses | 200.11M | 293.28M | 236.19M | 188.43M | 150.63M | 36.82M |
Interest Expense | 38.21M | 31.07M | 23.75M | 3.35M | 3.14M | 3.97M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 207.44M | 300.5M | 243.01M | 196.72M | 160.4M | 113.78M |
Income Tax Expense | -93K | 2.36M | 18.19M | 2.5M | n/a | n/a |
Shares Outstanding (Basic) | 8.5M | 7.68M | 6.02M | 5.07M | 4.61M | 3.26M |
Shares Outstanding (Diluted) | 8.5M | 7.68M | 6.02M | 5.07M | 4.61M | 3.26M |
EPS (Basic) | -22.49 | -29.60 | -17.80 | -23.50 | -22.90 | -9.90 |
EPS (Diluted) | -22.49 | -29.60 | -17.80 | -23.50 | -22.90 | -9.90 |
EBITDA | -145.65M | -180.45M | -67.92M | -105.07M | -97.56M | -23.75M |
EBIT | -152.97M | -187.67M | -74.73M | -113.36M | -102.4M | -28.05M |
Depreciation & Amortization | 7.32M | 7.22M | 6.82M | 8.29M | 4.84M | 4.3M |
Add to Watchlist
Select watchlists to add or remove STRO